| Literature DB >> 23881756 |
R C Steggerda1, J C Balt, K Damman, M P van den Berg, J M Ten Berg.
Abstract
BACKGROUND: Alcohol septal ablation (ASA) provides symptomatic relief in most but not all patients with hypertrophic obstructive cardiomyopathy (HOCM). Therefore we investigated predictors of outcome after ASA.Entities:
Year: 2013 PMID: 23881756 PMCID: PMC3824733 DOI: 10.1007/s12471-013-0453-4
Source DB: PubMed Journal: Neth Heart J ISSN: 1568-5888 Impact factor: 2.380
Baseline characteristics
| Variables | Outcome after ASA |
| |
|---|---|---|---|
| Successful ( | Unsuccessful ( | ||
| Age (years) | 56 ± 17 | 57 ± 14 | 0.93 |
| Male sex (% (n)) | 55 (41) | 44 (17) | 0.32 |
| NYHA functional class | 2.9 ± 0.4 | 2.8 ± 0.7 | 0.78 |
| Angina functional class | 1.9 ± 0.4 | 2.0 ± 0.4 | 0.33 |
| Syncope (% (n)) | 23 (17) | 18 (7) | 0.71 |
| β-blocker or Ca-blocker (% (n)) | 83 (63) | 78 (29) | 0.52 |
| Previous pacemaker (% (n)) | 5 (4) | 0 (0) | 0.36 |
| Max CK (U/l) | 1294 ± 461 | 1431 ± 793 | 0.34 |
| Max CK Mb (U/l) | 201 ± 124 | 167 ± 59 | 0.051 |
| Hospital stay, days | 5.6 ± 4 | 6.3 ± 5 | 0.49 |
| Angiographic findings | |||
| - Non-ablated branch present (% (n)) | 26 (19) | 50 (19) | 0.01 |
| - Distance to ablated branch (mm) | 16 ± 7 | 20 ± 8 | 0.006 |
| - Diameter ablated branch (mm) | 1.7 ± 0.4 | 1.6 ± 0.5 | 0.25 |
| - Diameter non-ablated branch (mm) | 1.0 ± 0.3 | 1.1 ± 0.4 | 0.32 |
| - Amount of alcohol (ml) | 2.4 ± 0.7 | 2.3 ± 0.5 | 0.55 |
| - Number of ablated branches | 1.2 ± 0.4 | 1.2 ± 0.4 | 0.99 |
| - Invasive gradient pre ASA (mmHg) | 83 ± 32 | 95 ± 35 | 0.08 |
Data are presented as mean ± standard deviation or as percentage (number)
ASA alcohol septal ablation, CCS Canadian Cardiovascular Society, CK creatine kinase, NYHA New York Heart Association
Echocardiographic findings at baseline and 4 months follow up
| Variables | Outcome after ASA |
| |
|---|---|---|---|
| Baseline | Successful ( | Unsuccessful ( | |
| Septal thickness (mm) | 22 ± 5 | 22 ± 5 | 0.95 |
| Posterior wall thickness (mm) | 15 ± 3 | 16 ± 3 | 0.71 |
| End-diastolic volume (ml) | 77 ± 25 | 74 ± 26 | 0.63 |
| End-systolic volume (ml) | 18 ± 11 | 16 ± 7 | 0.20 |
| Ejection fraction (%) | 76 ± ? | 78 ± ? | 0.41 |
| LVOT min (mm) | 14 ± 5 | 13 ± 5 | 0.66 |
| Degree of MI | 1.5 ± 1.0 | 1.7 ± 1.1 | 0.50 |
| Degree of SAM | 2.9 ± 0.6 | 3.0 ± 0.6 | 0.14 |
| Resting gradient (mmHg) | 43 ± 40 | 63 ± 46 | 0.026 |
| Provoked gradient (mmHg) | 107 ± 53 | 126 ± 67 | 0.15 |
| At 4-month follow-up | |||
| Septal thickness (mm) | 20 ± 4 | 20 ± 4 | 0.43 |
| Posterior wall thickness (mm) | 14 ± 3 | 14 ± 3 | 0.62 |
| End-diastolic volume (ml) | 81 ± 27 | 74 ± 24 | 0.14 |
| End-systolic volume (ml) | 23 ± 15 | 18 ± 9 | 0.053 |
| Ejection fraction (%) | 74 ± 10 | 77 ± 10 | 0.16 |
| LVOT min (mm) | 19 ± 4 | 15 ± 5 | <0.001 |
| LVOT min, increase | 5.6 ± 4 | 1.7 ±3 | <0.001 |
| Degree of MI | 0.5 ± 0.7 | 1.0 ± 1.0 | 0.020 |
| Degree of SAM | 1.0 ± 0.9 | 2.2 ± 1.1 | <0.001 |
| Akinetic basal septum (% (n)) | 72 (55) | 19 (7) | <0.001 |
| Without sparing basal septum (% (n)) | 58 (45) | 17 (6) | <0.001 |
| Resting gradient (mmHg) | 12 ± 7 | 41 ± 38 | <0.001 |
| Provoked gradient (mmHg) | 17 ± 10 | 91 ± 53 | <0.001 |
| Decrease provoked gradient (mmHg) | 91 ± 53 | 35 ± 60 | <0.001 |
Data are presented as mean ± standard deviation or as percentage (number)
LVOT left ventricular outflow tract, MI Mitral insufficiency, SAM systolic anterior motion
Univariate and multivariate predictors of unsuccessful outcome
| Variable | Univariate | Multivariate | ||
|---|---|---|---|---|
| OR (95 % CI) |
| OR (95 % CI) |
| |
| Age | 1.00 (0.97–1.03) | 0.87 | ||
| Sex (males) | 1.50 (0.68–3.32) | 0.32 | ||
| Baseline resting gradient (per 5 mmHg) | 1.06 (1.01–1.11) | 0.024 | 1.06 (1.01–1.11) | 0.024 |
| Distance to ablated branch (per mm) | 1.08 (1.03–1.55) | 0.005 | 1.09 (1.03–1.16) | 0.004 |
| Non-ablated branch present | 2.85 (1.24–6.53) | 0.013 | ||
OR odds ratio
Multivariate predictors of successful outcome taking into account the interaction between the distance to the ablated branch and the presence of a non-ablated branch
| Variable | N | Univariate | Mulitvariate | ||
|---|---|---|---|---|---|
| OR (95 % CI) |
| OR (95 % CI) |
| ||
| Baseline resting gradient (per 5 mmHg) | 1.06 (1.01–1.11) | 0.024 | 1.05 (1.00–1.10) | 0.061 | |
| Distance vs non-ablated branch | |||||
| - Distance < 19 mm, non-ablated branch not present | 54 | 1.00 | – | 1.00 | – |
| - Distance ≥ 19 mm, non-ablated branch not present | 21 | 0.99 (0.30–3.21) | 0.98 | 1.14 (0.33–3.88) | 0.83 |
| - Distance < 19 mm, non-ablated branch present | 11 | 0.32 (0.36–2.70) | 0.29 | 0.40 (0.05–3.52) | 0.41 |
| - Distance ≥ 19 mm, non-ablated branch present | 27 | 5.36 (1.97–14.57) | 0.001 | 5.88 (2.06–16.74) | 0.001 |
OR odds ratio
Distance: the measured distance from the origin of the LAD to the origin of the ablated septal branch